The double blinded, randomized placebo-controlled trial to evaluate the improvement effects of Oligonol ingestion on hidden obesity in healthy women.

The double blinded, randomized placebo-controlled trial to evaluate the improvement effects of Oligonol ingestion on hidden obesity in healthy women. - The improvement effects of Oligonolingestion on hidden obesity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018905

Enrollment

Registered

2015-09-04

Start date

2015-07-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidden obesity of healthy subjects

Interventions

Active: Oligonol 100 mg/day (1 capsule/day) for 12 weeks. Placebo: dextrin (1 capsule/day) for 12 weeks.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Person who was diagnosed as health by doctor 2. Aged 18-25 3. Person that informed consent was provided and agreed to participate in the study

Exclusion criteria

Exclusion criteria: 1. Person having a disease 2. Person who takes medicine 3. Current smokers 4. Person having food allergy 5. Person who was diagnosed as an incompetent by doctor

Design outcomes

Primary

Measure	Time frame
Body compositions including body fat percentage, body weight and BMI: 0, 4, 8, 12 weeks	—

Secondary

Measure	Time frame
Blood lipid- and glucose- related markers including triglyceride, cholesterol, glucose, HbA1c, adiponectine,leptine etc.	—

Countries

Japan

Contacts

Public ContactMasaki Taga

Wayo Women's University Department of Health and Nutrition

m-taga@wayo.ac.jp047-371-1591

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026